skip to main content

MDS suitability for valproate — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateDispensing and SupplyMDS suitability for valproateGPhC CRA

A care home asks for sodium valproate gastro-resistant tablets to be placed into a monitored dosage system. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Check product suitability and clinical governance before repackaging

Not every medicine is suitable for repackaging into an MDS, and valproate carries important safety warnings. This makes check product suitability and clinical governance before repackaging the single best answer in this scenario. The other options would either miss the key safety issue, delay appropriate review, or fail to meet the relevant clinical or professional requirement.

Reference: MEP; BNF; SmPC